Cargando…

Effects of anti-TNF therapy on ophtalmological complications in children with rheumatic diseases

Detalles Bibliográficos
Autores principales:	Frkovic, Marijan, Vukojevic, Nenad, Jelusic, Marija
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191333/ http://dx.doi.org/10.1186/1546-0096-12-S1-P236

Ejemplares similares

Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients
por: Ferreira, Natalia, et al.
Publicado: (2015)

HOW TO TREAT PATIENTS AFTER SERIOUS ADVERSE EFFECTS CAUSED BY TNF INHIBITORS?
por: Sršen, Saša, et al.
Publicado: (2020)

COMPARISON OF DIFFERENT DIAGNOSTIC GUIDELINES FOR THE DIAGNOSIS OF MACROPHAGE ACTIVATION SYNDROME COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: SINGLE CENTRE EXPERIENCE
por: Jelušić, Marija, et al.
Publicado: (2018)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

PReS-FINAL-2320: Different clinical presentation of takayasu arthritis: case report of two pediatric patients
por: Rukavina, I, et al.
Publicado: (2013)

Successful use of adalimumab as a conservative treatment for bilateral knee lipoma arborescens in patient with psoriatic juvenile idiopathic arthritis – case report and review of literature
por: Frkovic, Marijan, et al.
Publicado: (2022)

PReS-FINAL-2015: Demographic, clinical and laboratory features of juvenile dermatomyositis in Croatia: retrospective study over the last 22 years
por: Frković, M, et al.
Publicado: (2013)

Pulmonary thromboembolism in children with rheumatic diseases
por: Vogler, Larry B, et al.
Publicado: (2012)

Clinical and immunological characteristics of rheumatic diseases in children
por: Chyzheuskaya, Iryna, et al.
Publicado: (2014)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
por: Marco, A, et al.
Publicado: (2008)

Risk of latent tuberculosis in at-risk children with rheumatic diseases
por: Lim, SC, et al.
Publicado: (2011)

Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
por: Espada, G, et al.
Publicado: (2011)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Clinical and functional effectiveness of anti-TNF therapy in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalia, et al.
Publicado: (2011)

Monitoring of anti-TNF biological treatments
por: Ruiz del Agua, A, et al.
Publicado: (2010)

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
por: Ziaee, V, et al.
Publicado: (2008)

Systemic rheumatic diseases in the ICU
por: Vernikos, P, et al.
Publicado: (2009)

Imunological and clinical characteristics in children with polyarteritis nodosa: a retrospective study over the last 20 years
por: Topic, Masa Vikic, et al.
Publicado: (2011)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
por: Tarkiainen, M, et al.
Publicado: (2008)

PReS-FINAL-2314: Anti-TNF alpha therapy for refractory childhood takayasu arthritis
por: Koren, B, et al.
Publicado: (2013)

Corticosteroid related changes in body mass index in children and adolescents with rheumatic diseases
por: Shiff, Natalie, et al.
Publicado: (2012)

TNF-alfa blockers- promising therapy for chronic uveitis in very young children
por: Tauber, T, et al.
Publicado: (2008)

Decreased plating efficiency, proliferation and osteogenic differentiation of synovial fluid mesenchymal progenitors as a marker of severity of juvenile idiopathic arthritis
por: Mosler, Elvira Lazic, et al.
Publicado: (2012)

Helicobacter pylori infection in rheumatic diseases
por: Wen, Hongyan, et al.
Publicado: (2012)

Predictors of response and anti-TNF drugs comparative efficacy
por: Canhão, Helena, et al.
Publicado: (2011)

Heart rate variability in Egyptian children with acute rheumatic fever
por: Farid, MM, et al.
Publicado: (2009)

Synovial fibroblast hyperplasia correlates with rheumatoid arthritis duration and activity and is partially reversed by anti-TNF therapy
por: Izquierdo, E, et al.
Publicado: (2010)

Osteoblast differentiation from synovial fluid cells in juvenile idiopathic arthritis (JIA)
por: Jelusic-Drazic, Marija, et al.
Publicado: (2012)

PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
por: Christensen, AE, et al.
Publicado: (2013)

Effectiveness of tnf inhibitors therapy in children with juvenile idiopathic arthritis aged 2 to 5 years
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2014)

Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center
por: Espada, G, et al.
Publicado: (2011)

Use of anti-TNF Etanercept in paediatric patients with autoimmune disease and ocular involvement: the Parma experience
por: Rossi, M, et al.
Publicado: (2008)

Influence of the cognitive aspects of caregivers in the adhesion of treatment in children and adolescents with chronic rheumatic diseases-preliminary data
por: Keppeke, Lívia, et al.
Publicado: (2014)

Update of the japanese national registry of pediatric rheumatic disease
por: Yamagchi, Ken-Ichi, et al.
Publicado: (2014)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
por: Tynjälä, P, et al.
Publicado: (2008)

Understanding the biology and use of anti-TNF agents in JIA – interim results
por: Lovell, Daniel J, et al.
Publicado: (2012)

Influence of variants of Fcg receptor IIA on the European league against rheumatism responses to anti-tumour necrosis factor alpha therapy in psoriatic arthritis
por: Ramirez, J, et al.
Publicado: (2010)

High levels of DEK autoantibodies may predict early flare following cessation of anti-TNF therapy in juvenile idiopathic arthritis
por: Mor-Vaknin, Nirit, et al.
Publicado: (2014)

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab
por: Edgson, Lucy, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4cdvgqfncfg6b11d35v0mec7jl